OncologyTube

09/18/2024

FDA approves Kisqali for early high-risk breast cancer treatment: a new option to reduce the likelihood of cancer recurrence.

09/11/2024

Nivolumab Combo Phase 3 TiNivo 2 Results + Tivozanib in RCC Presented at ESMO 2024 AVEO Oncology Bristol Myers Squibb ESMO - European Society for Medical Oncology

In this video, we explore the groundbreaking results from the TiNivo-2 Phase 3 trial, presented at the 2024 European Society for Medical Oncology (ESMO) Cong...

08/09/2024

Breast Cancer Genetic Testing – Should Doctors Use ctDNA? Nathalie McDowell Johnson, MD

Dr. Nathalie M. Johnson, MD, highlights the importance of circulating tumor DNA (ctDNA) testing in breast cancer management. Find out how ctDNA can benefit patients with triple-negative or HER2-positive disease.

08/05/2024

90% Patients Unaware Of Simple Genetic Test for Cancer – Kevin Hughes, MD MUSC Health

Dr. Kevin Hughes discusses the problem with current genetic testing practices and highlights the need for increased awareness and utilization of testing for cancer predisposition.

08/02/2024

Genetic Testing Cancer, Practice Changing? – Dr. Erica Giblin, MD The American Society of Breast Surgeons Erica Marie Giblin

Uncover the impact of ctDNA monitoring on the detection and treatment of breast cancer recurrences. Discover how this innovative approach is changing the landscape of oncology.

06/05/2024

ASCO 2024 Phase 3 IMROZ Results Evaluating Sarclisa (Isatuximab) + VRd in Transplant-Ineligible NDMM Sanofi American Society of Clinical Oncology

Dr. Zandra Klippel as she presents the groundbreaking Phase 3 results from the IMROZ study at ASCO 2024. This study evaluates the efficacy of Sarclisa (isatu...

06/05/2024

Alexis LeVee from City of Hope at American Society of Clinical Oncology Medical Oncology Association of Southern California, Inc. ASCO 2024 Palbociclib, Pembrolizumab & Endocrine Therapy: Outcomes & Gut Microbiome in HR+/HER2- MBC

Dr. Alexis LeVee from City of Hope presents innovative findings from a Phase 1b clinical trial combining CDK4/6 inhibitors with PD-1 inhibitors for hormone r...

06/05/2024

Regina Barragán Carrillo City of Hope presents American Society of Clinical Oncology data on Latino Gut Microbiome at

📺 Description:Welcome to our latest video from the ASCO 2024 conference! In this presentation, Dr. Regina Barragan-Carillo from Cedar Folk Comprehensive Can...

06/05/2024

ASCO 2024 - Hedyeh Ebrahimi, MD City of Hope American Society of Clinical Oncology - Multicenter analysis of high-dose chemotherapy (HDCT) regimens for the treatment of patients with recurrent germ cell tumors (GCTs)

Join us as Dr. Hedyeh Ebrahimi from City of Hope presents a groundbreaking study led by Dr. Alex Chehrazi Rafel at the ASCO 2024 conference. This collaborati...

05/24/2024

TOP 5 Presentations To See NYU Langone Health Orlando Health Cedars-Sinai The Angeles Clinic and Research Institute

Christian U. Blank - Neoadjuvant nivolumab plus ipilimumab versus adjuvant nivolumab in macroscopic, resectable stage III melanoma: The phase 3 NADINA trial.
https://lnkd.in/gTU2FZhH

Jeffrey S. Weber - Individualized neoantigen therapy mRNA-4157 (V940) plus pembrolizumab in resected melanoma: 3-year update from the mRNA-4157-P201 (KEYNOTE-942) trial.
https://lnkd.in/gf-ZdF9u

Sajeve Samuel Thomas - Efficacy and safety of lifileucel, an autologous tumor-infiltrating lymphocyte cell therapy, and pembrolizumab in patients with immune checkpoint inhibitor-naive unresectable or metastatic melanoma: Updated results from IOV-COM-202 cohort 1A.
https://lnkd.in/g3Rp4_y5

Omid Hamid - Phase 1 safety and efficacy of IMC-F106C, a PRAME × CD3 ImmTAC bispecific, in post-checkpoint cutaneous melanoma (CM).
https://lnkd.in/gXsqG4bF

Paolo Antonio Ascierto - Efficacy and safety of triplet nivolumab, relatlimab, and ipilimumab (NIVO + RELA + IPI) in advanced melanoma: Results from RELATIVITY-048.
https://lnkd.in/ghZuhN2D

04/30/2024

VIDEO: CAR T-cell Therapy in CLL (chronic lymphocytic leukemia): Navigating the Landscape and Looking Ahead with Catherine Coombs, MD

Introduction During a comprehensive presentation by Dr. Catherine Coombs at UC Irvine, insights into the unique challenges and opportunities of using CAR T-c

04/30/2024

VIDEO: Advancing Acute Lymphoblastic Leukemia Treatment with CAR-T Cells: Insights from Dr. Anjali Advani https://oncologytube.com/advancing-acute-lymphoblastic-leukemia-treatment-with-car-t-cells-insights-from-dr-anjali-advani/ Cleveland Clinic

Introduction At a recent conference, Dr. Anjali Advani of the Cleveland Clinic discussed the transformative role of Chimeric Antigen Receptor T-cell (CAR-T)

04/30/2024

VIDEO: Utility of ctDNA in CAR-T and bispecific therapy with Dr. Brian Sworder, MD

Introduction During the CAR-T & Bispecifics Conference, Dr. Brian Sworder, MD, from UCI Irvine, shared compelling insights on the utility of circulating

04/30/2024

MD Anderson Cancer Center Nitin Jain, MD Challenging case involving advanced B-cell lymphoblastic leukemia (BLL) from the CAR-T and Bispecifics Conference [2024]

Introduction During the recent CAR-T & Bispecifics conference, Dr. Nitin Jain, MD, from MD Anderson Cancer Center in Houston, Texas, presented a challeng

04/30/2024

Enhertu DESTINY-Breast06 Phase III Study the Impact on HR-Positive, HER2-Low Metastatic Breast Cancer Revealed
https://oncologytube.com/enhertu-destiny-breast06-phase-iii-study-the-impact-on-hr-positive-her2-low-metastatic-breast-cancer-revealed/ AstraZeneca US Hope Rugo

Introduction The recent findings from the DESTINY-Breast06 Phase III trial signify a potential shift in the treatment landscape for HR-positive, HER2-low met

04/10/2024

Video: https://oncologytube.com/revolutionizing-pancreatic-cancer-detection-the-groundbreaking-role-of-liquid-biopsies-ajay-goel-phd-aacr-2024/ City of Hope American Association for Cancer Research (AACR)

Uncover a revolutionary approach to pancreatic cancer detection. Delve into the study's methodology and learn how microRNAs are used in liquid biopsies for unparalleled accuracy.

03/02/2024

Interesting CRISPR News

Take a closer look at MEGA-CRISPR, a new tool in cancer therapy. Learn how this RNA-targeting technology is set to redefine precision medicine and revolutionize genetic research.

03/02/2024

FDA Approves Amivantamab with Chemo for First-Line NSCLC with EGFR Exon 20 Insertion Mutations [EXCLUSIVE VIDEO]

FDA grants approval for amivantamab-vmjw in lung cancer treatment. Find out how this therapy is changing the landscape of NSCLC treatment.